A wellness study of 108 individuals using personal, dense, dynamic data clouds
Nature Biotechnology, 2017
Price N., Magis A., Earls J., Glusman G., Levy R., Lausted C., McDonald D., Kusebauch U., Moss C., Zhou Y., Qin S., Moritz R., Brogaard K., Omenn G., Lovejoy J., Hood L.
Disease area | Application area | Sample type | Products |
---|---|---|---|
Wider Proteomics Studies | Wellness Studies | Plasma | Olink Target 96 |
Abstract
This is the first publication from the Lee Hood/Arivale P4 medicine intiative; a pilot/POC study based on 108 individuals (the Pioneer 100 Wellness Project). Samples were collected every 3 months over a 9 month period and “personal dense dynamic data clouds” were created for each individual. Data was collected from multiple sources, such as whole genome sequencing, a range of >200 clinical tests, measurement of >600 metabolites and extensive gut microbiome charachterization. Proteomics was also a key part of these data clouds, with 262 different proteins measured (>60% of those using Olink CVD I and Inf). Activity and lifestyle parameters were also monitored, and a behavioural coach was provided for each participant. Changes in data over time (including those in response to behaviourial changes after coaching) were assessed, as well as correlations between different multi-omics parameters. This was analyzed in an “unsupervised” manner to reveal ~70 densely interconnected “communities” of correlating parameters. These often turned out represent physiologically related analytes, such as for cardiometabolic health. Several specific observations were highlighted, including levels of gamma-glutamyltyrosine being densely connected with a range of clinical analytes for cardiometabolic disease, and the genetic risk of inflammatory bowel disease being negatively correlated with plasma cystine. Overall though, this is presented as a proof of concept rather than to establish specific associations, and as the pilot for a much larger project to assess 100 000 subjects.